Herpes simplex virus type 1 (HSV-1) establishes life-long infections of the human host characterized by productive infection of actively cycling epithelial cells and fibroblasts at the site of primary infection, and non productive latent infection of growth-arrested sensory neurons. The ability of the virus to express productive cycle genes at high levels in some cells but not in others lies at the heart of the pathogenic mechanism of the clinically important virus. We have recently demonstrated that transcription and replication HSV-1 requires the activities of cyclin-dependent kinases recently demonstrated that transcription and replication of HSV-1 requires the activities of cyclin-dependent kinases (cdks), a family of cellular proteins whose phosphorylating activities are expressed differentially in mammalian cells as a function of cell type and growth-status. Using cdk inhibitors and HSV-1 mutant viruses, we will test the hypothesis that specific cdks together with well-characterized viral regulatory proteins, VP16, and immediate-early proteins ICPs 0, 4, 22, 27, mediate the distinct programs of viral gene expression characteristic of productive infection and latency. More specifically, we propose 1) to determine whether cdks- 1,-2 and/or -3 are required for HSV-1 transcription and replication in cells of neural and non-neural lineage, 2) to identify HSV-1 infection- related factors that activate cdks in cells of neural and non-neural lineage, 3) to determine whether the transactivating activities of VP16, ICPO and the CTAs cells of neural and non-neural lineage, 4) to examine the effects of the cdks and ICPO on the post-translational modification of IE regulatory proteins in cells of neural and non-neural lineage, 5) to determine whether the activities of cdks -1, -2 and/or -5 are essential for reactivation of HSV-1 from neuronal latency and if so, to establish the order of viral gene expression that occurs in latently infected neurons after reversal of a drug-induced block in the activities of these cdks, and 6) To assess the effect of the continuous expression of ICPO on the establishment, maintenance and reactivation of latency in vivo. Knowledge of the molecular basis for the dual cycle- cycle of HSV-1 generated in these studies will provide the means to develop successful strategies for the prevention and control of diseases caused by HIV-1 and other neurotropic herpesviruses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA020260-26
Application #
6328871
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Daschner, Phillip J
Project Start
1980-03-01
Project End
2003-11-30
Budget Start
2001-12-01
Budget End
2002-11-30
Support Year
26
Fiscal Year
2002
Total Cost
$412,374
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Mostafa, Heba H; Thompson, Thornton W; Kushnir, Anna S et al. (2011) Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol 85:12631-7
Kushnir, Anna S; Davido, David J; Schaffer, Priscilla A (2010) Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol 84:188-200
Bowman, J Jason; Schaffer, Priscilla A (2009) Origin of expression of the herpes simplex virus type 1 protein U(S)1.5. J Virol 83:9183-94
Bowman, J Jason; Orlando, Joseph S; Davido, David J et al. (2009) Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus. J Virol 83:8733-43
Boutell, Chris; Everett, Roger; Hilliard, Joshua et al. (2008) Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82:10647-56
Bringhurst, Ryan M; Dominguez, Antonia A; Schaffer, Priscilla A (2008) Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant. J Virol 82:11472-5
Orlando, Joseph S; Balliet, John W; Kushnir, Anna S et al. (2006) ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions. J Virol 80:9381-90
Bringhurst, Ryan M; Schaffer, Priscilla A (2006) Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- viruses. J Virol 80:4528-37
Davido, David J; von Zagorski, William F; Lane, William S et al. (2005) Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79:1232-43
Davido, David J; Von Zagorski, William F; Maul, Gerd G et al. (2003) The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J Virol 77:12603-16

Showing the most recent 10 out of 30 publications